Fredrick Nahm - Myomo Medical Director

MYO Stock  USD 6.38  0.17  2.74%   

Director

Dr. Fredrick Nahm, M.D. Ph.D. is the Medical Director of the company. He is an actively practicing neurologist. He is the founder and managing partner at Neurology of Greenwich, Medical Director at Greenwich Hospital, and President at NeuroCare Health. U. of Michigan Medical School and Salk Institute at UCSD .
Professional MarksPh.D
Address 137 Portland Street, Boston, MA, United States, 02114
Phone617 996 9058
Webhttps://myomo.com

Myomo Management Efficiency

The company has Return on Asset of (0.3145) % which means that on every $100 spent on assets, it lost $0.3145. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.8254) %, meaning that it generated no profit with money invested by stockholders. Myomo's management efficiency ratios could be used to measure how well Myomo manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of December 2024, Return On Tangible Assets is likely to drop to -0.59. In addition to that, Return On Capital Employed is likely to drop to -0.95. At this time, Myomo's Net Tangible Assets are very stable compared to the past year. As of the 11th of December 2024, Non Currrent Assets Other is likely to grow to about 97 K, while Total Assets are likely to drop about 10.4 M.
Myomo Inc has 601.3 K in debt with debt to equity (D/E) ratio of 0.07, which may show that the company is not taking advantage of profits from borrowing. Myomo Inc has a current ratio of 3.35, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Myomo to invest in growth at high rates of return.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts. Myomo operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 87 people. Myomo Inc (MYO) is traded on NYSE MKT Exchange in USA. It is located in 137 Portland Street, Boston, MA, United States, 02114 and employs 101 people. Myomo is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Myomo Inc Leadership Team

Elected by the shareholders, the Myomo's board of directors comprises two types of representatives: Myomo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Myomo. The board's role is to monitor Myomo's management team and ensure that shareholders' interests are well served. Myomo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Myomo's outside directors are responsible for providing unbiased perspectives on the board's policies.
Paul Gudonis, Chief Executive Officer, Director
Harry MD, Chief Officer
Joseph Chicoskie, Director Marketing
Colin Anderson, Global Operations
Galina Shtivelman, Senior Resources
David Henry, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Fredrick Nahm, Medical Director
Steve Kelly, Founder, Chairman of the Board, President and Chief Operating Officer
Micah Mitchell, Chief Officer
Jonathan Naft, General Manager - O&P

Myomo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Myomo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Myomo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myomo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myomo will appreciate offsetting losses from the drop in the long position's value.

Moving together with Myomo Stock

  0.95GH Guardant HealthPairCorr
  0.79LH LaboratoryPairCorr

Moving against Myomo Stock

  0.77DRIO DarioHealth CorpPairCorr
  0.68EDAP EDAP TMS SAPairCorr
  0.64VERO Venus ConceptPairCorr
  0.32CI Cigna Corp Downward RallyPairCorr
  0.32VTAK Catheter Precision Earnings Call Next WeekPairCorr
The ability to find closely correlated positions to Myomo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myomo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myomo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myomo Inc to buy it.
The correlation of Myomo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myomo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myomo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Myomo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Myomo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myomo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myomo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myomo Inc Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.23)
Revenue Per Share
0.835
Quarterly Revenue Growth
0.813
Return On Assets
(0.31)
Return On Equity
(0.83)
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.